We are live on ! Find out more
WCMNY

Westchester Capital Management (New York) Portfolio holdings

AUM $2.21B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+99.86%
5 Year Est. Return
+236.34%
10 Year Est. Return
+1,523.35%
AUM
$3.64B
AUM Growth
+$85.7M
Cap. Flow
-$35.8M
Cap. Flow %
-0.98%
Top 10 Hldgs %
32.26%
Holding
629
New
150
Increased
117
Reduced
17
Closed
182

Sector Composition

Rank Sector Weight
1 Financials 41.42%
2 Technology 12.77%
3 Healthcare 11.09%
4 Industrials 10.67%
5 Energy 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCVA
51
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
$13.4M 0.37%
1,322,060
+556,981
+73% +$5.53M
STRE
52
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
$12.9M 0.35%
1,280,418
+182,637
+17% +$1.83M
XPO icon
53
PUT
XPO
XPO
$24.5B
$12.7M 0.35%
382,100
-1,289,456
-77% -$43.4M
GSQD
54
DELISTED
G Squared Ascend I Inc.
GSQD
$12.4M 0.34%
1,225,205
+231,195
+23% +$2.31M
DNAB
55
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$12.3M 0.34%
1,225,583
+1,192,380
+3,591% +$11.8M
HHLA
56
DELISTED
HH&L Acquisition Co.
HHLA
$12.3M 0.34%
1,219,240
+896,522
+278% +$8.98M
BLEU
57
DELISTED
bleuacacia ltd Class A Ordinary Shares
BLEU
$12.2M 0.33%
+1,213,839
New +$12.1M
NAAC
58
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
$12M 0.33%
1,185,536
+399,500
+51% +$4.01M
FINM
59
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
$12M 0.33%
1,181,524
+225,520
+24% +$2.26M
NCAC
60
DELISTED
Newcourt Acquisition Corp Class A Ordinary Share
NCAC
$12M 0.33%
1,167,081
+1,080,237
+1,244% +$11M
TVGN icon
61
Tevogen Inc. Common Stock
TVGN
$27.3M
$11.7M 0.32%
22,630
+18,523
+451% +$9.48M
ROSS
62
DELISTED
Ross Acquisition Corp II
ROSS
$11.7M 0.32%
1,154,403
+710,617
+160% +$7.12M
PUCK
63
DELISTED
Goal Acquisitions Corp. Common Stock
PUCK
$11.7M 0.32%
1,161,254
MDH
64
DELISTED
MDH Acquisition Corp.
MDH
$11.6M 0.32%
1,148,107
+498,107
+77% +$4.97M
HCNE
65
DELISTED
Jaws Hurricane Acquisition Corp. Class A Common Stock
HCNE
$11.6M 0.32%
1,156,981
+685,164
+145% +$6.77M
DNAD
66
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$11.5M 0.32%
1,145,236
+691,162
+152% +$6.87M
WRAC
67
DELISTED
Williams Rowland Acquisition Corp.
WRAC
$11.5M 0.32%
1,119,035
+869,035
+348% +$8.82M
TWNI
68
DELISTED
Tailwind International Acquisition Corp.
TWNI
$10.8M 0.3%
1,067,669
+150,000
+16% +$1.5M
WPCA
69
DELISTED
Warburg Pincus Capital Corporation I-A
WPCA
$10.6M 0.29%
1,051,003
+473,046
+82% +$4.73M
PACX
70
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
$10.6M 0.29%
1,046,364
+509,049
+95% +$5.11M
PDOT
71
DELISTED
Peridot Acquisition Corp. II
PDOT
$10.6M 0.29%
1,049,456
+522,200
+99% +$5.22M
WYNN icon
72
Wynn Resorts
WYNN
$10.6B
$10.5M 0.29%
+126,900
New +$9.29M
WYNN icon
73
PUT
Wynn Resorts
WYNN
$10.6B
$10.5M 0.29%
+126,900
New +$9.29M
DNZ
74
DELISTED
D and Z Media Acquisition Corp.
DNZ
$10.3M 0.28%
1,030,117
+980,117
+1,960% +$9.79M
WQGA
75
DELISTED
World Quantum Growth Acquisition Corp.
WQGA
$10.2M 0.28%
+1,000,218
New +$10.1M

Similar funds

Westchester Capital Management (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Westchester Capital Management (New York) held 629 positions worth $3.64B, up 2.4% from $3.55B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Westchester Capital Management (New York)'s Q4 2022 filing shows 150 new, 117 increased, 17 reduced and 182 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $143M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 32% a quarter earlier, followed by Technology and Healthcare.

  • Westchester Capital Management (New York)'s largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M.
  • Westchester Capital Management (New York) added most to Signify Health, Inc. in Q4 2022, an estimated $49.6M increase.
  • Westchester Capital Management (New York)'s biggest Q4 2022 reduction was Silicon Motion, cutting an estimated $61.4M.
  • Westchester Capital Management (New York) fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $143M.
  • Westchester Capital Management (New York)'s ten largest holdings make up 32% of its $3.64B portfolio in Q4 2022.
  • Westchester Capital Management (New York) opened 150 new positions and closed 182 in Q4 2022.
  • Westchester Capital Management (New York)'s portfolio value rose 2.4% quarter-over-quarter to $3.64B.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.